Trial NCT00612612

View at ClinicalTrials.gov 
Aliases: NCT00574938
Org. Study IDs: NCI-2009-00254
Secondary IDs: 07-100 7945 CDR0000582311 NCI-2009-00254 U01CA062490

Last trial update was posted on 2013-09-30

MeSH Interventions

Fludarabine Fludarabine phosphate Obatoclax Rituximab

MeSH Conditions

Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Lymphoid Leukemia, Prolymphocytic

Other Conditions

B-cell Chronic Lymphocytic Leukemia Prolymphocytic Leukemia Refractory Chronic Lymphocytic Leukemia Stage I Chronic Lymphocytic Leukemia Stage II Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage IV Chronic Lymphocytic Leukemia

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID